Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Antitubercular Agents MeSH Descriptor Data 2026


MeSH Heading
Antitubercular Agents
Tree Number(s)
D27.505.954.122.085.255
Unique ID
D000995
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000995
Annotation
consider also MYCOBACTERIUM TUBERCULOSIS /‌drug eff & TUBERCULOSIS /‌drug ther
Scope Note
Drugs used in the treatment of tuberculosis. They are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
Entry Term(s)
Anti-Tuberculosis Agent
Anti-Tuberculosis Agents
Anti-Tuberculosis Drug
Anti-Tuberculosis Drugs
Antitubercular Agent
Antitubercular Drug
Antitubercular Drugs
Antituberculars
Tuberculostatic Agent
Tuberculostatic Agents
Registry Numbers
0
See Also
Tuberculosis
Tuberculosis, Multidrug-Resistant
Public MeSH Note
1966
History Note
1966
Date Introduced
1966/01/01
Last Updated
2026/01/01
Antitubercular Agents Preferred
page delivered in 0.152s